« Safety of Estrogen-Based Feminizing Gender-Affirming Hormone Therapy:  A Practical Endocrine Approach to Risk Stratification and Monitoring ». 2026. Canadian Diabetes & Endocrinology Today 4 (1): 10–16. https://doi.org/10.58931/cdet.2026.4150.